Meta Title : How Much Does Humira Cost Without Insurance in the U.S 2025?

Meta Description: Humira costs approximately $7,300 per month without insurance. Many patients reduce costs by switching to biosimilars or using manufacturer assistance.

How Much Does Humira Cost Without Insurance in the U.S.?

The average cash price for a standard supply of Humira without insurance is around $7,300. Humira (adalimumab) is a biologic injection used to treat several autoimmune conditions like rheumatoid arthritis, Crohn’s disease, and psoriasis.

With the arrival of lower-priced biosimilar versions in 2023, patients now have more options, but navigating costs remains complex. This guide breaks down the prices you might see at the pharmacy, explains how insurance coverage works, and provides a clear list of strategies to significantly lower your out-of-pocket expenses.

Key Takeaways

• The list price for Humira is very high, but most patients use savings programs or insurance and pay far less.
• Biosimilar versions of adalimumab entered the U.S. market in 2023 and can offer substantial savings, sometimes over 80% off Humira's list price.
• Multiple savings routes exist, including manufacturer copay cards, patient assistance programs, and pharmacy coupons.
• Insurance coverage is shifting toward biosimilars, with major pharmacy benefit managers (PBMs) like CVS Caremark removing brand-name Humira from their standard formularies.
• Effective cost management requires proactive steps: discussing biosimilars with your doctor, applying for all eligible programs, and comparing pharmacy prices.

What Is the Typical Cost of Humira Without Insurance?

If you pay out of pocket, the cost of Humira is substantial. The price you see is often called the "list price" or "cash price," and it does not include any discounts, rebates, or insurance payments.

A standard carton containing two 40 mg/0.4 mL pens has an average cash price of around $7,300. This is for the most common adult dose for conditions like rheumatoid arthritis. Since treatment typically requires two pens per month, the annual cost can approach $90,000 or more at the list price.

It is important to know that this is the starting point for negotiations with insurance companies. Very few patients actually pay this full amount. The final "net price" after all rebates and discounts is much lower. However, if you are uninsured and not using a savings program, this is the price a pharmacy may initially quote.

How Do Humira and Adalimumab Biosimilars Compare on Price?

Since 2023, patients have had access to biosimilar versions of adalimumab. A biosimilar is a biological product that is very similar to the original brand-name drug, with no clinically meaningful differences in safety or effectiveness. Their introduction has created a new dynamic in pricing.

A key finding from 2023 is that while biosimilar options are available, their uptake has been slower than expected. By the end of 2023, they accounted for less than 2% of all adalimumab prescriptions. However, their presence has driven down costs across the board. The competition has led to a nearly 50% decrease in the overall net spending on adalimumab products.

Biosimilars have launched with different pricing strategies:

• High-List-Price Biosimilars: Priced slightly below Humira (5-10% discount), competing for placement on insurance formularies.
• Low-List-Price Biosimilars: Priced dramatically lower (55-86% discount) to appeal to cash-paying patients and cost-conscious plans.

Major pharmacy benefit managers (PBMs) are now driving this change. For example, CVS Caremark removed brand-name Humira from its largest commercial formularies in 2024, favoring a biosimilar with an 81% lower list price. This kind of move by a large PBM can force a major shift in the market and lower costs for many patients.

What Factors Affect the Long-Term Cost of Humira?

Several key elements determine what you will pay for Humira or its biosimilars over time. Understanding these can help you find the best way to manage expenses.

• Your Insurance Plan's Formulary: This is the list of drugs your plan covers. Insurers and PBMs are increasingly preferring biosimilars over brand-name Humira to control costs. Whether your plan covers the brand, a biosimilar, or neither has the biggest impact on your price.
• Dosage and Frequency: The cost is directly tied to how much medicine you use. A standard adult dose for rheumatoid arthritis is typically 40 mg every other week. However, doses for conditions like Crohn's disease can be higher or more frequent, which increases the monthly and annual cost.
• Biosimilar vs. Brand-Name: Opting for an approved biosimilar, if appropriate for your condition, is often the most straightforward way to achieve lower costs. Some biosimilars are also "interchangeable," meaning a pharmacist may substitute them for the brand-name product without needing a new prescription from your doctor, depending on state law.
• Your Pharmacy: Cash prices can vary between pharmacies, including local retail, specialty, and mail-order pharmacies. It is worth calling a few to compare if you are paying out of pocket.

Does Insurance, Medicare, or Medicaid Cover Humira?

Most insurance plans do cover Humira or one of its biosimilars, but with specific rules.

• Commercial Private Insurance: Most employer-sponsored or marketplace plans cover Humira. They often require prior authorization, meaning your doctor must prove it is medically necessary before the plan will pay. Many also use step therapy, requiring you to try less expensive drugs first. For commercially insured patients, the manufacturer's Humira Complete Savings Card can often reduce copays to as little as $5 per month.
• Medicare Part D: Humira is covered by most Medicare Part D prescription drug plans. A key update for 2025 is the new out-of-pocket spending cap. Everyone with Part D will pay no more than $2,000 per year for covered drugs. Importantly, manufacturer copay cards are not available to patients on federal programs like Medicare.
• Medicaid: State Medicaid programs generally cover Humira, often with a very low copay (e.g., $20 or less per month). Coverage details and preferred drug choices (brand vs. biosimilar) can vary significantly from state to state.

What Are the Best Ways to Save on Humira?

You do not have to pay the full list price. Here are proven strategies to lower your costs, starting with the most impactful.

Apply for a Humira Copay Savings Card

If you have commercial insurance, this is your first step. The Humira Complete Savings Card is offered by the manufacturer, AbbVie, and can reduce your monthly out-of-pocket cost to as little as $0 to $5 per prescription. You can sign up online at HUMIRASavingsCard.com, through the Humira Complete app, or by calling 1-800-4HUMIRA.

Important Note: This card is not for patients on Medicare, Medicaid, TRICARE, or any other government-funded insurance program.

Apply for a Patient Assistance Program

If you are uninsured, underinsured, or have a high financial burden, you may qualify for free medication.

• myAbbVie Assist: This is AbbVie's patient assistance program. It provides Humira at no cost to qualifying patients with limited income and no prescription coverage. You can call 1-800-222-6885 or visit the program website to check eligibility and apply.
• Nonprofit Foundations: Organizations like the Patient Advocate Foundation or the HealthWell Foundation may offer grants to help with copays or other medical expenses related to chronic illnesses.

Explore Other Practical Savings Strategies

• Discuss Biosimilars with Your Doctor: Have an open conversation with your specialist about whether a lower-cost adalimumab biosimilar is a safe and effective alternative for you. This can lead to the single biggest reduction in cost.
• Request a 90-Day Supply: If you are on stable, long-term therapy, getting a three-month supply from a mail-order pharmacy can reduce your total copays and dispensing fees over a year.
• Use Polar Bear Meds Coupons and Discounts; If you are paying out of pocket, every dollar counts. In addition to manufacturer coupons, pharmacy coupon programs can be a powerful tool to significantly lower the cash price you see at the register. You can check current discounts on our coupon page.

When Should You Talk to Your Specialist About Switching or Alternatives?

Having a proactive conversation with your doctor is one of the most powerful tools for managing costs. Here is when to schedule that talk:

• During your annual check-up or treatment review.
• If you receive a notification from your insurance that your coverage for Humira is changing or that a biosimilar is now preferred.
• If your out-of-pocket costs increase suddenly, making your medication unaffordable.
• Before you reach the Medicare Part D "donut hole" (coverage gap) or the new $2,000 out-of-pocket cap, to plan for the year ahead.

Your doctor can help you navigate clinical questions about biosimilars, assist with prior authorization forms for insurance, and discuss other therapeutic alternatives if cost becomes a barrier to your treatment.